Skip to main content
OpenTrials
Completed

NCT Number: NCT02242331

Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure

This post-marketing surveillance study is designed to supplement under conditions of normal clinical practice data on safety, tolerability and efficacy of Micardis® collected in clinical studies with special emphasis on the control of blood pressure in the morning before intake of the next antihypertensive drug

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Essential hypertension
  • At least 18 years of age

Exclusion criteria

  • NA

Treatment and study plan

Micardis®

Drug

Primary outcomes

  1. Change from baseline in blood pressure

    Time frame: Baseline, after 3 months

    with special emphasis on the morning blood pressure, before intake of the next antihypertensive treatment

  2. Number of patients with adverse events

    Time frame: up to 3 months

  3. Changes from baseline in pulse rate

    Time frame: Baseline, after 3 months

Secondary outcomes

  1. Assessment of efficacy by investigator on 5- point scale

    Time frame: after 3 months

  2. Assessment of tolerability by investigator on a 5-point scale

    Time frame: after 3 months

Sponsors and collaborators

Lead sponsor

Boehringer Ingelheim

Industry

Registry information

Official study title

Risk of Morning Hypertension

Important dates

Study start
2001
Primary completion
2002
First posted
Sep 17, 2014
Registry last updated
Sep 17, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.